18702 N. CREEK PARKWAY, BOTHELL, WA
Amendment to License Agreement with Bristol-Myers Squibb - $20M Paid
Reports Second Quarter 2026 Financial Results and Provides Business Update
Immunome, Inc. 2026 Annual Meeting Results; Directors Elected
Reports First Quarter 2026 Financial Results and Provides Business Update
Annual Report to Security Holders
Reports Full Year 2025 Financial Results and Provides Business Update
Announces Pricing of Public Offering of Common Stock
Investor Presentation
Q2
Q1
FY 2025
Q3
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Definitive Proxy Statement
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Schedule 13G - Ownership Report